Pee Safe Raises $32 Mn as OrbiMed Bets on India’s Hygiene Market

Personal hygiene and wellness brand Pee Safe has raised $32 million (approximately ₹265 crore) in its Series C funding round, led by global healthcare investment firm OrbiMed.

The fresh capital will be used to strengthen Pee Safe’s core operations, accelerate product innovation, expand retail and distribution, and scale its presence across hygiene and wellness categories. The company offers a wide range of products across menstrual care, intimate hygiene, toilet hygiene, and grooming, including sanitary pads, menstrual cups, intimate washes, and toilet seat sanitizers.

Founded in 2017 and operating under Redcliffe Hygiene Private Limited, Pee Safe reported ₹82.5 crore in revenue in FY25, registering 44% year-on-year growth, and has significantly reduced losses as it moves closer to breakeven,

Commenting on the fundraise, Vikas Bagaria, Co-founder and CEO of Pee Safe, said:

“Building Pee Safe has been a decade-long journey in a category that demands patience, persistence, and deep belief. This capital allows us to strengthen our foundations and stay focused on what matters most—building better products, reaching more people, and creating meaningful impact in hygiene and wellness. We’re grateful to OrbiMed for their trust as we enter this next phase of growth.”

The round also saw continued support from existing investors including Alkemi Growth Capital, Venture Catalyst, NATCO Pharma, Rainmatter by Zerodha, Zerodha, and several prominent angel investors.

Pee Safe is led by a founding team comprising Vikas Bagaria, Dheeraj Jain, Rithish Kumar, and Srijana Bagaria, and currently employs around 140 people.

The transaction was advised by InCred Capital.

With this Series C funding, Pee Safe aims to consolidate its leadership position in India’s hygiene and wellness market while continuing to invest in consumer education, product quality, and sustainable growth.

Peesafe funding Rounds